Quantcast
Last updated on April 16, 2014 at 1:21 EDT

Latest Ventricular assist device Stories

2013-08-22 16:24:40

PLEASANTON, Calif., Aug. 22, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it will be participating in the Morgan Stanley 2013 Health Care Conference on Monday, September 9. Taylor C. Harris, Vice President and Chief Financial Officer, will provide an update on the company, beginning at 10:50 a.m., Pacific Daylight Time (1:50 p.m., Eastern...

2013-08-15 08:28:41

NEW YORK, August 15, 2013 /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Today, Investors' Reports announced new research reports highlighting CareFusion Corporation (NYSE: CFN), Teleflex Incorporated (NYSE: TFX), The Cooper Companies Inc. (NYSE: COO), HeartWare International Inc. (NASDAQ: HTWR), and Thoratec Corp. (NASDAQ: THOR). Today's readers may access these reports free of charge - including full price targets,...

2013-08-09 16:22:31

FRAMINGHAM, Mass. and SYDNEY, Aug. 9, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Canaccord Genuity 2013 Annual Growth Conference at 3:00 p.m. EDT on Wednesday, August 14, 2013. The conference is being held August 14-15 at the The...

2013-08-08 23:02:56

AAHFN promotes awareness of heart failure readmissions, rewards members for assisting patients with managing their disease. Mount Laurel, N.J. (PRWEB) August 08, 2013 The American Association of Heart Failure Nurses (AAHFN) is pleased to announce the winners of the 30-Day Readmission Award. The award recognizes heart failure (HF) treatment programs that have shown exceptional performance in the management of heart failure patients through significant reduction in patients’ readmission...

2013-07-31 16:28:08

- Revenue of $130.5 million for the second quarter of 2013, an increase of 10% year-over-year PLEASANTON, Calif., July 31, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, today reported its financial results for the second quarter and first half of 2013. "Thoratec delivered strong results during the second quarter, supported by our leadership positions...

2013-07-20 23:00:22

MarketResearchReports.Biz announces addition of new report “Global Cardiac Bio Implant Devices (Implantable Cardioverter Defibrillators, Implantable Cardiac Pacemakers, Heart Valve, Coronary Stent, Peripheral Stent, Ventricular Assist Device) Market Forecast, Clinical Trials, M&A” to its database. Visit:...

2013-07-19 08:26:32

FRAMINGHAM, Mass. and SYDNEY, July 19, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ:HTWR, ASX:HIN) has scheduled a conference call to discuss its financial results for the three months ended June 30, 2013, at 8:00 a.m. U.S. Eastern Daylight Time on Thursday, August 8, 2013. The Company plans to release the financial results prior to the conference call. The conference call with management will discuss the Company's financial results, highlights from the second...

2013-07-01 08:27:15

PLEASANTON, Calif., July 1, 2013 /PRNewswire/ -- Thoratec Corporation (NASDAQ: THOR), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, said today it has acquired the DuraHeart(®) II ("DH-II") ventricular assist system from Terumo Corporation (TSE: 4543 Section 1) for an upfront cash payment of $13 million and potential future milestone payments, based on regulatory approvals and product sales, of up to $43.5...

2013-06-17 08:29:28

- Amended protocol includes enhanced blood pressure monitoring to ensure optimal patient management - FRAMINGHAM, Mass., and SYDNEY, June 17, 2013 /PRNewswire/ -- HeartWare International, Inc. (Nasdaq: HTWR; ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that the U.S. Food and Drug Administration (FDA) has granted conditional approval to an IDE...

2013-06-13 08:28:38

FRAMINGHAM, Mass. and SYDNEY, June 13, 2013 /PRNewswire/ -- HeartWare International, Inc. (NASDAQ: HTWR - ASX: HIN), a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced that CEO Doug Godshall is scheduled to present at the Wells Fargo Securities Research and Economics 2013 Healthcare Conference at 9:25 a.m. EDT on Tuesday, June 18, 2013. The conference is being held June 18-19 at...


Latest Ventricular assist device Reference Libraries

0_886104d1c1c698f3a531e056704457d5
2010-10-14 16:46:25

The artificial heart, a mechanical heart replacement, is typically used in order to bridge the time to heart transplant or to replace the heart in case a transplant is impossible. Often ventricular assist devices are confused with mechanical hearts because the assist the heart through pumps. They are also different from a cardiopulmonary bypass machine which is an external device used to provide the function of the heart and lungs. CPBs are usually only used for a few hours at a time,...

More Articles (1 articles) »